Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-11-14 to 2024-11-25
Current total value of award: $133.8
Description: 8511018153!DILTIAZEM HYDROCHLO